Table 1.
The demographic and clinical characteristics of the AITDs patients and the controls
| Characteristics | GD patients (n = 701 ) | HT patients (n = 360) | Controls (n = 938) |
|---|---|---|---|
| Gender | |||
| Male (%) | 214(30.5) | 44(12.2) | 309(32.9) |
| Female (%) | 487(69.5) | 316(87.8) | 629(67.1) |
| Age (mean ± SD) | 36.86 ± 14.549 | 35.09 ± 13.786 | 38.61 ± 9.202 |
| Age of onset | 33.98 ± 14.344 | 32.79 ± 13.465 | - |
| ≤18 years | 113(16.12) | 51(14.2) | - |
| ≥19 years | 588(83.88) | 309(85.8) | - |
| Thyroid size | - | ||
| Normal size (%) | 22(3.1) | 12(3.3) | - |
| Degree I (%) | 127(18.1) | 59(16.4) | - |
| Degree II (%) | 425(60.7) | 253(70.3) | - |
| Degree III (%) | 127(18.1) | 36(10.0) | - |
| Family history (%) | 174(24.8) | 79(21.9) | |
| Ophthalmopathy (%) | 135(19.3) | 9(2.5) | - |
| Thyroid antibodies | - | ||
| TPOAb | 398(56.7) | 252(70.0) | - |
| TgAb | 303(43.2) | 226(62.8) | - |